Results 1 - 20 of 44,412 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (42,651)
Refined by:
subject:
General & Internal Medicine
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung CancerThe New England journal of medicine, 2020-10, Vol.383 (18), p.1711-1723 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2027071 ;PMID: 32955177Full text available |
| 2 |
Material Type: Article
|
|
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung CancerThe New England journal of medicine, 2019-11, Vol.381 (21), p.2020-2031 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1910231 ;PMID: 31562796Full text available |
| 3 |
Material Type: Article
|
|
Adjuvant chemotherapy for resected early‐stage non‐small cell lung cancerCochrane database of systematic reviews, 2015-03, Vol.2015 (3), p.CD011430-CD011430 [Peer Reviewed Journal]Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;ISSN: 1469-493X ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD011430 ;PMID: 25730344Full text available |
| 4 |
Material Type: Article
|
|
Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung CancerThe New England journal of medicine, 2022-01, Vol.386 (3), p.241-251 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2112431 ;PMID: 34534430Full text available |
| 5 |
Material Type: Article
|
|
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerThe New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1709937 ;PMID: 28885881Full text available |
| 6 |
Material Type: Article
|
|
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLCThe New England journal of medicine, 2020-10, Vol.383 (14), p.1328-1339 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1917346 ;PMID: 32997907Full text available |
| 7 |
Material Type: Article
|
|
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung CancerThe New England journal of medicine, 2018-05, Vol.378 (22), p.2078-2092 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1801005 ;PMID: 29658856Full text available |
| 8 |
Material Type: Article
|
|
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung CancerThe New England journal of medicine, 2023-02, Vol.388 (6), p.489-498 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2212083 ;PMID: 36780674Full text available |
| 9 |
Material Type: Article
|
|
Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics studyPLoS medicine, 2018-11, Vol.15 (11), p.e1002711 [Peer Reviewed Journal]COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 Hosny et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Hosny et al 2018 Hosny et al ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1002711 ;PMID: 30500819Full text available |
| 10 |
Material Type: Article
|
|
Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and TreatmentMayo Clinic proceedings, 2019-08, Vol.94 (8), p.1623-1640 [Peer Reviewed Journal]2019 Mayo Foundation for Medical Education and Research ;Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved. ;COPYRIGHT 2019 Elsevier, Inc. ;ISSN: 0025-6196 ;EISSN: 1942-5546 ;DOI: 10.1016/j.mayocp.2019.01.013 ;PMID: 31378236Full text available |
| 11 |
Material Type: Article
|
|
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLCThe New England journal of medicine, 2023-07, Vol.389 (2), p.137-147 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2304594 ;PMID: 37272535Full text available |
| 12 |
Material Type: Article
|
|
Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk ProfilingAmerican journal of respiratory and critical care medicine, 2016-03, Vol.193 (5), p.542-551 [Peer Reviewed Journal]Copyright American Thoracic Society Mar 1, 2016 ;ISSN: 1073-449X ;EISSN: 1535-4970 ;DOI: 10.1164/rccm.201505-1040OC ;PMID: 26485620Full text available |
| 13 |
Material Type: Article
|
|
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLCThe New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1809697 ;PMID: 30280658Full text available |
| 14 |
Material Type: Article
|
|
Neoadjuvant PD-1 Blockade in Resectable Lung CancerThe New England journal of medicine, 2018-05, Vol.378 (21), p.1976-1986 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1716078 ;PMID: 29658848Full text available |
| 15 |
Material Type: Article
|
|
Lung cancer: current therapies and new targeted treatmentsThe Lancet (British edition), 2017-01, Vol.389 (10066), p.299-311 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 21, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)30958-8 ;PMID: 27574741 ;CODEN: LANCAOFull text available |
| 16 |
Material Type: Article
|
|
Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib: 2 CARE-compliant case reportsMedicine (Baltimore), 2021-03, Vol.100 (10), p.e25046-e25046 [Peer Reviewed Journal]Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000025046 ;PMID: 33725888Full text available |
| 17 |
Material Type: Article
|
|
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLCThe New England journal of medicine, 2020-01, Vol.382 (1), p.41-50 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1913662 ;PMID: 31751012Full text available |
| 18 |
Material Type: Article
|
|
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung CancerThe New England journal of medicine, 2020-11, Vol.383 (21), p.2018-2029 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2027187 ;PMID: 33207094Full text available |
| 19 |
Material Type: Article
|
|
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung CancerThe New England journal of medicine, 2018-01, Vol.378 (2), p.113-125 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1713137 ;PMID: 29151359Full text available |
| 20 |
Material Type: Article
|
|
Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trialBMC medicine, 2022-02, Vol.20 (1), p.42-42, Article 42 [Peer Reviewed Journal]2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-022-02245-z ;PMID: 35101045Full text available |
Results 1 - 20 of 44,412 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (42,651)
Refine My Results
Creation Date
- Before 1960 (1,757)
- 1960 To 1975 (2,239)
- 1976 To 1991 (3,449)
- 1992 To 2008 (9,971)
- After 2008 (27,025)
-
More options
New Records
- New From Last Month (18)
- New From Last 3 Month (339)
-
More options
Resource Type
- Articles (44,338)
- magazinearticle (53)
- Book Chapters (17)
- Books (2)
- Conference Proceedings (1)
- Reviews (1)
-
More options
Subject
- Science & Technology (44,409)
- Life Sciences & Biomedicine (44,408)
- Medicine, General & Internal (31,529)
- Humans (31,165)
- Male (15,913)
- Female (14,260)
- Critical Care Medicine (12,676)
- Middle Aged (10,896)
- Respiratory System (10,457)
- Adult (8,705)
- Aged (8,329)
- Biological And Medical Sciences (7,713)
- Medical Sciences (7,641)
- Lung Cancer (6,303)
- Lungs (5,870)
- Lung Diseases (5,726)
- Patients (5,214)
- Animals (3,440)
- Mortality (3,177)
-
More options
Databases
- MEDLINE (33,317)
- ProQuest Central (29,909)
- PubMed Central (25,803)
- DOAJ Directory of Open Access Journals (15,456)
- GFMER Free Medical Journals (15,305)
- ROAD: Directory of Open Access Scholarly Resources (9,818)
- HighWire Press (Free Journals) (6,501)
- ProQuest One Psychology (4,353)
- Journals@Ovid Open Access Journal Collection Rolling (2,964)
- IngentaConnect Free/Open Access Journals (2,060)
- Wolters Kluwer Open Health (1,686)
- Coronavirus Research Database (1,617)
- Freely Accessible Japanese Titles (1,611)
- Springer Nature OA/Free Journals (1,599)
- Cochrane Library (Open Aceess) (946)
- BMJ Open Access Journals (832)
- Wiley-Blackwell Open Access Titles (648)
- KoreaMed Synapse (555)
- KoreaMed Open Access (460)
- Taylor & Francis Open Access (460)
-
More options
Language
Journal Title
- American Journal Of Respiratory And Critical Care Medicine (4,408)
- Bmj (3,444)
- British Medical Journal (2,731)
- Chest (4,418)
- Curēus (1,457)
- Intensive Care Medicine (1,096)
- Internal Medicine (1,244)
- Medicine (1,685)
- The Lancet (1,898)
- The New England Journal Of Medicine (2,047)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||